Altay Therapeutics
San Francisco
About Altay Therapeutics
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It was founded in 2019 and is headquartered in San Francisco, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.2M
- Funding stage: Seed
- Last round: Seed (Sep 2022)
- Website: altaytherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Canonical: https://fsome.com/organization/altay-therapeutics-95537 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.